Glucose intolerance and decreased early insulin response in mice with severe hypertriglyceridemia

Experimental Biology and Medicine

Volumn 235, Issue 1, 2010, Pages 40-46

  Ding, Yi Lei ^a   Wang, Yu Hui ^b   Huang, Wei ^b   Liu, George ^b   Ross, Colin ^c   Hayden, Michael R ^c   Yang, Jin Kui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Glucose homeostasis; Insulin secretion; Lipoprotein lipase

Indexed keywords

FATTY ACID; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERTRIGLYCERIDEMIA; INSULIN RELEASE; INSULIN RESPONSE; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN;

ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; HYPERTRIGLYCERIDEMIA; INSULIN; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PANCREAS;

MUS;

EID: 76749091433     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2009.009100     Document Type: Article

References (30)

1. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with type 2 diabetes. Diabetes 1997;48:1354-9
2. Eto M, Watanabe K, Makino I, Ishii K. Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type-IIb, III, IV and V hyperlipoproteinemia). Metabolism 1991;40:776-80
3. Goldberg U, Merkel M. Lipoprotein lipase, physiology, biochemistry, and molecular biology. Front Biosci 2001;6:d388-405
4. Olivecrona T, Hernell O, Egelrud T. Lipoprotein lipase. Adv Exp Med Biol 1975;52:269-79
5. Gehrisch S. Common mutations of the lipoprotein lipase gene and their clinical significance. Curr Atheroscler Rep 1999;1:70-8
6. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002;287:2570- 81
7. Lin CY, Chen MF, Lin LY, Liau CS, Lee YT, Su TC. Insulin resistance is the major determinant for microalbuminuria in severe hypertriglyceridemia: implication for high-risk stratification. Intern Med 2008;47:1091- 7
8. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002;106:2137-42
9. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuechker K, Hanefeld M. Post-challenge plasma glucose and glycemic spike are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-4
10. Tushuizen ME, Diamant M, Heine RJ. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med J 2005;81:1-6
11. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006;3:482-9
12. Ross CJ, Liu G, Kuivenhoven JA, Twisk J, Rip J, van Dop W, Excoffon KJ, Lewis SM, Kastelein JJ, Hayden MR. Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation. Arterioscler Thromb Vasc Biol 2005;25:2143-50
13. Tershakovec AM, Rader DJ. Disorders of lipoprotein metabolism and transport. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson's Textbook of Pediatrics, 17th edn. Philadelphia: Saunders (Elsevier), 2004: 445-59
14. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999;96:329-39
15. Gunton JE, Kulkarni RN, Yim SH, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR. Loss of ARNT/HIFβ mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005;122:337-49
16. Zhao T, Guo J, Li H, Huang W, Xian X, Ross CJ, Hayden MR, Wen Z, Liu G. Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia. Biochem Biophys Res Commun 2006;341:1066-71
17. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65
18. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003;26:2910-4
19. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 2001;44:929-45
20. Hu YM, Liu W, Huang R, Zhang XY. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 2006;47:1908-14
21. Muurling M, van den Hoek AM, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ. Overexpression of apoC1 in ob/ob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 2004;45:9-16
22. Jong MC, Voshol PJ, Muurling M, Dahlmans VE, Romijn JA, Pijl H, Havekes LM. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes 2001;50:2779-85
23. Reaven GM, Mondon CE, Chen YD, Breslow JL. Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. J Lipid Res 1994;35:820-4
24. Pappan KL, Pan Z, Kwon G, Marshall CA, Coleman T, Goldberg U, McDaniel ML, Semenkovich CF. Pancreatic β-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. J Biol Chem 2005;280:9023-9
25. Haffner SM, Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 1997;103:152-62
26. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995;44:1038-45
27. Mcgarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:718
28. Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X, Fan J, Ross C, Karasinska J, Hayden MR, Liu G. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res 2008;102:250-6
29. Wang J, Xian X, Huang W, Chen L, Wu L, Zhu Y, Fan J, Ross C, Hayden MR, Liu G. Expression of LPL in endothelial-intact artery results in lipid deposition and vascular cell adhesion molecular-1 upregulation in both LPL and apoE-deficient mice. Arterioscler Thromb Vasc Biol 2007;27:197-203
30. Lupattelli G, Lombardini R, Schillaci G, Ciuffetti G, Marchesi S, Siepi D, Mannarino E. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 2000;140:521-6